title: [Intravitreal ranibizumab in the treatment of subretinal neovascularization in a case of punctate inner choroidopathy].
abstract: METHODS
  We report the case of a 28-year old woman suffering loss of visual acuity in her left eye, who presented an image suggestive of a subretinal neovascular membrane in her left eye, and bilateral retinal lesions compatible with punctate inner choroidopathy (PIC). She was treated with intravitreal ranibizumab obtaining excellent results.
  
  
  CONCLUSIONS
  The differential diagnosis must be made between PIC and the rest of "white dot syndromes" and the presumed ocular histoplasmosis syndrome (POHS). Antiangiogenic drugs may be a good alternative for the treatment of such diseases when they develop a subretinal neovascular membrane.
authors.affiliation: Servicio de Oftalmología, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España. Electronic address: bea83jdm@hotmail.com.
authors.forename: B
authors.initials: B
authors.lastname: Jiménez
authors.affiliation: Servicio de Oftalmología, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España.
authors.forename: I
authors.initials: I
authors.lastname: Pinilla
authors.affiliation: Servicio de Oftalmología, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España.
authors.forename: J A
authors.initials: JA
authors.lastname: Cristóbal
authors.affiliation: Servicio de Oftalmología, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España.
authors.forename: E
authors.initials: E
authors.lastname: Mínguez
authors.affiliation: Servicio de Oftalmología, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España.
authors.forename: D
authors.initials: D
authors.lastname: Pérez
authors.affiliation: Servicio de Oftalmología, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España.
authors.forename: N
authors.initials: N
authors.lastname: Cruz
authors.affiliation: Servicio de Oftalmología, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España.
authors.forename: C
authors.initials: C
authors.lastname: Peiro
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D058449:Intravitreal Injections; D000069579:Ranibizumab; D015866:Uveitis, Posterior / Q000188:drug therapy* / Q000473:pathology
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000069579:Ranibizumab
keywords: Angiogenesis inhibitors; Angiografía fluoresceínica; Antiangiogénicos; Coroidopatía punctata interna; Fluorescein angiography; Membrana neovascular; Neovascular membrane; Punctate inner choroidopathy; Ranibizumab